.

Dr Ian Maidment

Ian Maidment

Senior Lecturer in Clinical Pharmacy

Research Theme

Chronic and Communicable Conditions

Research Centre

Aston Research Centre for Healthy Ageing (ARCHA) 

Profile


I joined Pharmacy at Aston in February 2012, having spent the previous 25 years as a practicing pharmacist. I have worked within community, industry, acute hospital and particularly within old age and adult psychiatry where I worked for 18 years; with 9 years at a senior level. In November 2013 I obtained my PhD on – Medication-related adverse events in older people with dementia; causes and possible solutions.

I am an experienced researcher, manager and clinician with a broad research background including working within multi-disciplinary international teams. I am experienced in aspects of management including strategic planning, knowledge management, team development, change management and administration, from both a public sector and commercial environment.

I have taught and developed teaching material for a variety of undergraduate and postgraduate courses. In particular I have developed a Psychopharmacology course for non-medical prescribers and educational material for the College for Postgraduate Pharmacy Education.

Teaching Activity
 

MPharm Programme

PH4703: lectures and workshops in clinical pharmacy
PH3601: Workshops in mental health and neurology
PH4704: Lectures on research methods
PH3609: Workshops on medication management in the NHS

OSPAP Programme

PMHPP4: lectures and workshops in clinical pharmacy

Postgraduate Psychiatric Pharmacy Programme

Lead Course Tutor for postgraduate Certificate, Diploma and MSc.


Qualifications & Education

  • PhD entitled - Medication-related adverse events in older people with dementia; causes and possible solutions, Aston University, 2013
  • MA in Health Service Research with Merit, University of Kent, 2010
  • Diploma Management Studies (distinction), Christchurch University, Canterbury, 2004
  • Diploma Psychiatric Pharmacy, De Montfort University, Leicester, 1996
  • BPharm (2:1), University of Bath, 1986
These BBC and ITV media clips feature Ian Maidment being interviewed about a study, which he was involved with as a co-investigator, which linked anti-cholinergic burden with cognitive impairment and mortality.

Employment

  • 2012 – date: Senior Lecturer in Clinical Pharmacy, Pharmacy, Aston University.
  • 2007 – 2011: Senior Pharmacist / Clinical Lead for R&D, Kent & Medway NHS and Social Care Partnership Trust.
  • 2002 – 2007: Chief Pharmacist for East Kent Partnership NHS Trust.
  • 2000 – 2002: Pharmacy services manager (mental health), Kent & Canterbury Hospital.
  • 1997 – 2000: Mental Health Pharmacist, Norfolk and Waveney Mental Health Trust.
  • 1996 – 1997: Clinical Audit Pharmacist, Royal Berkshire Hospital.
  • 1994 – 1996: Clinical Pharmacist, Thanet Hospital.
  • 1993 – 1994: Locum Pharmacist, St Mary’s Hospital, Isle of Wight.
  • 1988 – 1993: Community Pharmacy Manager.
  • 1987 – 1988: Basic Grade Pharmacist, Lewisham Hospital.
  • 1986 – 1987: Industrial / Hospital Pre-registration Pharmacist.

Research interests

  • Medication errors in mental health and dementia – widely published in this field and undertaken qualitative and quantitative research. This includes an analysis of all medication errors reported by Mental Health Trusts to the NPSA in a single year, which was part of Themed Review of Medication Safety Incidents (Safety in Doses; NPSA, 2009 – available on
    www.nrls.npsa.nhs.uk/resources/?EntryId45=61625).

  • Medication management in dementia – linked with international leaders in this field. Chair of grant-writing group, which is supported by Dementia and Neurogenerative Diseases (DeNDRoN).

  • Pharmacological interventions for agitation in dementia – co-principal investigator for 1st in world CTIMP (clinical trial of an investigation medicinal product) studying a pharmaceutical agent in dementia.

  • Anti-cholinergic burden (ACB) – investigator on two recently published trials, which studied the link between ACB, and cognition and mortality (one study, which identified an association between mortality and ACB, received widespread international publicity).
    http://www.ncbi.nlm.nih.gov/pubmed/21926432

    http://www.ncbi.nlm.nih.gov/pubmed/21707557
      

  • Member of the Dementia and Neurogenerative Diseases (DeNDRoN) Dementia Research Network Clinical Studies Group.

  • Member of trial monitoring committee for Drug Safety Research Unit (DSRU) observational trial.

Recent research funding

  • 2014 – Pharmacy Research UK - £54,000 – Chief Investigator - A qualitative scoping study exploring the role of the community pharmacist in medication management in people with dementia dwelling in the community.
  • 2014 – NIHR – Mental Health Research Network – £13,000 – Chief Investigator - Study to investigate barriers to recruiting people with mental health problems to clinical trials involving medicinal products.
  • 2006 – 2010: PI with responsibility for medication management in an investigator initiated clinical trial studying memantine in agitation associated with dementia (MAGD; £389,000).
  • 2006 – 2008: Hospital Medicines Management Collaborative – 3rd wave (£30,000).
  • 2004 – 2006: Parkinson’s Disease Society to review the data, and produce a Cochrane review on Parkinson’s Disease Dementia (£5,000).

PhD Supervision

Currently: Co-supervision of PhD with Jo Lumsden from EAS – Developing a Mobile App to assess adherence to medication in people with dementia

Possible availability to supervise new suitable applicants in the following areas:

  • Medication management in dementia and mental health.
  • Medication review in the healthcare of older people including dementia and mental health.
  • The impact of anti-cholinergic burden on health outcomes.

Media Work

  • 2012: Extensive media coverage including national press (Express and Telegraph) of BMC paper, which suggested that official figures under-estimate the usage of anti-psychotics. 
  • 2011: Two TV (including live interview for BBC news 24), three radio and two press interviews (Daily Telegraph and Daily Mail) and press conference regarding trial published in JAGS linking anti-cholinergic burden with cognitive impairment and mortality. (Story was also widely featured in other media outlets).

  • 2002: Radio broadcast for National Public Radio (USA) on the use of gabapentin as a mood stabilizer.

Membership of Professional Bodies

  • 2011: Member General Pharmaceutical Council.
  • 2011: Founder Member of the Royal Pharmaceutical Society.
  • 2006: Full member of British Association for Psychopharmacology.
  • 2002: Member of the College of Mental Health Pharmacy

Selected publications

Papers / articles

47 publications, 25 MEDLINE listed, in a range of well respected journals including - Annals of Pharmacotherapy, Acta Psychiatrica Scandinavica, Psychiatric Bulletin, Journal of Psychopharmacology, Cochrane Reviews, International Journal of Geriatric Psychiatry, Quality & Safety in Health Care, Journal of the American Geriatric Society.

Highlights include:

  • Child A, Clarke A, Fox C, Maidment ID. 2012. A pharmacy led program to review anti-psychotic prescribing for people with dementia. BMC Psychiatry, 12, 155. doi:10.1186/1471-244X-12-155. 
  • Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, et al. 2012. Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial. PLoS ONE 7(5): e35185. doi:10.1371/journal.pone.0035185
  • Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study (CFAS). Journal of the American Geriatric Society. First published online: 24 JUN 2011. DOI: 10.1111/j.1532-5415.2011.03491.x. (impact factor = 3.656). ISSN 0002-8614
  • Maidment ID, Brown P, Calnan M. 2011. An exploratory study of the role of trust in medication management within mental health services. International Journal of Clinical Pharmacy (impact factor = 1.037), 33, 614-20. ISSN 2210-7703
  • Maidment ID, Fox C, Boustani M, Katona C. 2011. Medication management – the missing link in dementia interventions. International Journal of Geriatric Psychiatry. (impact factor = 1.981), DOI: 10.1002/gps.2745. ISSN 0885-6230.
  • Fox C, Livingston G, Maidment ID et al. 2011. The Impact of anti-cholinergic burden in Alzheimer’s Disease – the Laser AD study. Age and Ageing (impact factor = 2.719). doi: 10.1093/ageing/afr102.
  • Maidment ID, Boustani M, Rodriguez J, Brown R, Fox C, Katona C. 2008. A systematic review of the use of memantine in agitation associated with dementia. Annals of Pharmacotherapy (impact factor = 2.453), 42, 32-38. ISSN 1060-0280.
  • Maidment ID, Haw C, Stubbs J, Fox C, Katona C, Dean-Franklin B. 2008. Medication Errors in Older People with mental health problems: a review. International Journal of Geriatric Psychiatry (impact factor = 1.981), 23, 564-73, ISSN 0885-6230.
  • Maidment I, Fox C, Boustani M. 2006. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database of Systematic Reviews (impact factor = 5.653), Issue 1. Art. No.: CD004747. DOI: 10.1002/14651858.CD004747.pub2.
  • Maidment ID, Paton C, Lelliott P. 2006. A Review of Medication Errors in Mental Health Care. Quality & Safety in Health Care (impact factor = 2.856), 15, 409-13. ISSN 1475-3898.

Conference presentations / posters

47 poster / oral presentations at a range of national and international conferences. Highlights include:

  • Fox C, Boustani M, Crugel M, Maidment ID et al. MAGD Trial - Memantine for Agitation in Alzheimer's Dementia. Annual Scientific Meeting at the American Geriatrics Society 2011, National Harbor, MD. Won Presidential Award for Best Poster.
  • Maidment ID, Fox C, Livingston G, Katona C, Coulton S, Smithard D, Boustani M. An observational longitudinal study using a previously validated tool of the anti-cholinergic burden in a cohort of 224 people with AD. Posters at the 2009 MHRN conference (awarded prize for 2nd best poster) and oral communication at the 19th IAGG World Congress of Gerontology and Geriatrics, 2009.

Editorial appointments / Peer reviewer

  • On the editorial boards of the Annals of Pharmacotherapy and Kent Journal for Mental Health.
  • Peer reviewer for Annals of Pharmacotherapy, Acta Psychiatrica Scandinavica, Pharmaceutical Journal, Current Medical Research & Opinion, Medical Letter, Drug Safety, European Journal of Paediatric Neurology, Journal of Affective Disorders, Expert Opinion, International Journal for Quality in Health Care, Journal of Mental Health, International Journal of Geriatric Psychiatry, BMC Geriatrics, CNS Drugs and Ageing & Mental Health, International Clinical Psychopharmacology, BMC Health Services Research, International Psychogeriatrics, Cochrane Collaboration. NICE Technology Assessments.
  • Grant reviewer for NIHR RfPB and Applied Programme Grants, and Evaluation, Trials and Studies Coordinating Centre.

Employable Graduates; Exploitable Research